Belpointe Asset Management’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-102
Closed -$1.27K – 1909
2023
Q1
$1.27K Hold
102
– – ﹤0.01% 3429
2022
Q4
$2K Buy
+102
New +$2.2K ﹤0.01% 3267
2021
Q3
– Sell
-2,253
Closed -$147K – 1213
2021
Q2
$147K Buy
2,253
+3
+0.1% +$190 0.01% 959
2021
Q1
$118K Hold
2,250
– – 0.01% 937
2020
Q4
$101K Buy
+2,250
New +$77.7K 0.01% 949

Other funds holding INGN

Belpointe Asset Management's INGN Position: Q2 2023 in Review

Belpointe Asset Management sold out of Inogen (INGN) in Q2 2023, closing a stake of 102 shares — an estimated $1.27K sold.

Belpointe Asset Management first reported a position in INGN in Q4 2020 and held it in 5 quarters. The position peaked at $147K in Q2 2021. 139 funds tracked by Wall St. Rank hold INGN as of Q2 2023.

  • Belpointe Asset Management reported no remaining Inogen position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 102 Inogen shares in Q2 2023, an estimated $1.27K.
  • Belpointe Asset Management first reported a position in Inogen in Q4 2020 and held it in 5 quarters.
  • Belpointe Asset Management's Inogen position peaked at $147K in Q2 2021.
  • 139 funds tracked by Wall St. Rank held Inogen as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.